Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using 177Lu-, 90Y-, and 225Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.

225Ac-3BP-3940 - 3B Pharma, Curanosticum

http://www.ncbi.nlm.nih.gov/pubmed/42225357

Aditi Mishra; Aleksandr Eismant; Andre Klega; Bastian Jaeschke; Christian Landvogt; Corinna Mueller; Daniel Benz-Zils; Elisabetta Perrone; Jingjing Zhang; Kriti Ghai; Lukas Greifenstein; Ortwin Klein; Richard P Baum; Tianzhi Zhao; Vivianne Jakobsson

Jun 2, 2026